Built at the Intersection: Chemistry First, AI-Native De Novo Small Molecule Discovery & Development
- Highlight EMMI as Terray Therapeutics’ full stack AI and experimental platform that brings together proprietary, ultra-high throughput hardware and lab automation with generative, predictive and selection AI models to aid expert scientists in developing novel solutions to some of medicine’s toughest problems
- Create your own specific and precise data and establish an integrated process and team structure that successfully deploys AI for small molecule drug discovery
- Highlight the platform and a use case